Population genetic structure of variable drug response

@article{Wilson2001PopulationGS,
  title={Population genetic structure of variable drug response},
  author={J. Wilson and M. Weale and A. Smith and F. Gratrix and B. Fletcher and Mark George Thomas and N. Bradman and D. Goldstein},
  journal={Nature Genetics},
  year={2001},
  volume={29},
  pages={265-269}
}
Geographic patterns of genetic variation, including variation at drug metabolizing enzyme (DME) loci and drug targets, indicate that geographic structuring of inter-individual variation in drug response may occur frequently. This raises two questions: how to represent human population genetic structure in the evaluation of drug safety and efficacy, and how to relate this structure to drug response. We address these by (i) inferring the genetic structure present in a heterogeneous sample and (ii… Expand
420 Citations
Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications
  • 13
  • Highly Influenced
Global patterns of genetic diversity and signals of natural selection for human ADME genes.
  • 70
  • PDF
Drug pathways: moving beyond single gene pharmacogenetics.
  • H. McLeod
  • Medicine, Biology
  • Pharmacogenomics
  • 2004
  • 15
Human population genetic structure and inference of group membership.
  • 305
  • PDF
Multiple Advantageous Amino Acid Variants in the NAT2 Gene in Human Populations
  • 52
  • PDF
Genetic variation and pharmacogenomics: concepts, facts, and challenges
  • 7
  • PDF
Large-scale SNP analysis reveals clustered and continuous patterns of human genetic variation
  • 138
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Molecular mechanisms of genetic polymorphisms of drug metabolism.
  • 514
  • PDF
Molecular mechanism of slow acetylation of drugs and carcinogens in humans.
  • 359
  • PDF
Consistent long-range linkage disequilibrium generated by admixture in a Bantu-Semitic hybrid population.
  • 69
  • PDF
A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin.
  • 219
  • PDF
...
1
2
3
...